0 0 0.00720602685882735 0.00720602685882735 0.00704225352112676 0.00720602685882735 -0.00248362266622988 -0.00507697346871933
Sign Up Today X
Thanks for submitting the form.
Stockreport

Gilead Sciences: From All-Time Highs To Higher Highs [Seeking Alpha]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Seeking Alpha
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Gilead expects Yeztugo sales to reach $100 million in Q4, even though it was only approved by the FDA on June 18 last year. Even weak sales of the oncology franchise in Q3 didn't prevent Gilead's EBIT margin from reaching a three-year high of 45.2%. And coupled with significant progress in its anito-cel, KITE-753, and KITE-363, I continue to believe GILD has an attractive risk/reward profile in 2026. Choreograph (Konstantin Yuganov)/iStock via Getty Images Since my article from October, "What To Expect From Gilead in Q3 2025" , Gilead Sciences' stock ( GILD ) reached an all-time high of $128.70. However, after November 20, a corrective pattern called a zigzag started to form. Currently, I expect it to end in mid-January. After This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of LEGN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not rec [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Gilead Sciences: From All-Time Highs To Higher Highs [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Seeking Alpha
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Gilead expects Yeztugo sales to reach $100 million in Q4, even though it was only approved by the FDA on June 18 last year. Even weak sales of the oncology franchise in Q3 didn't prevent Gilead's EBIT margin from reaching a three-year high of 45.2%. And coupled with significant progress in its anito-cel, KITE-753, and KITE-363, I continue to believe GILD has an attractive risk/reward profile in 2026. Choreograph (Konstantin Yuganov)/iStock via Getty Images Since my article from October, "What To Expect From Gilead in Q3 2025" , Gilead Sciences' stock ( GILD ) reached an all-time high of $128.70. However, after November 20, a corrective pattern called a zigzag started to form. Currently, I expect it to end in mid-January. After This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of LEGN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not rec [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS